Annual Accounts Receivable
$36.08 M
+$28.96 M+406.57%
December 31, 2023
Summary
- As of February 7, 2025, STRO annual accounts receivable is $36.08 million, with the most recent change of +$28.96 million (+406.57%) on December 31, 2023.
- During the last 3 years, STRO annual accounts receivable has risen by +$30.52 million (+549.00%).
- STRO annual accounts receivable is now at all-time high.
Performance
STRO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$6.66 M
-$295.00 K-4.24%
September 30, 2024
Summary
- As of February 7, 2025, STRO quarterly accounts receivable is $6.66 million, with the most recent change of -$295.00 thousand (-4.24%) on September 30, 2024.
- Over the past year, STRO quarterly accounts receivable has dropped by -$29.42 million (-81.55%).
- STRO quarterly accounts receivable is now -93.19% below its all-time high of $97.67 million, reached on June 30, 2022.
Performance
STRO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
STRO Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +406.6% | -81.5% |
| 3 y3 years | +549.0% | -81.5% |
| 5 y5 years | +1349.5% | -81.5% |
STRO Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +406.6% | -93.2% | at low |
| 5 y | 5-year | at high | +549.0% | -93.2% | +30.4% |
| alltime | all time | at high | +6152.7% | -93.2% | +309.8% |
Sutro Biopharma Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.66 M(-4.2%) |
| Jun 2024 | - | $6.95 M(-77.8%) |
| Mar 2024 | - | $31.30 M(-13.2%) |
| Dec 2023 | $36.08 M(+406.6%) | $36.08 M(+117.0%) |
| Sep 2023 | - | $16.63 M(+66.3%) |
| Jun 2023 | - | $10.00 M(+1.3%) |
| Mar 2023 | - | $9.87 M(+38.6%) |
| Dec 2022 | $7.12 M(-42.8%) | $7.12 M(-36.6%) |
| Sep 2022 | - | $11.24 M(-88.5%) |
| Jun 2022 | - | $97.67 M(+735.8%) |
| Mar 2022 | - | $11.69 M(-6.2%) |
| Dec 2021 | $12.45 M | $12.45 M(+1.0%) |
| Sep 2021 | - | $12.33 M(+34.6%) |
| Jun 2021 | - | $9.16 M(+26.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $7.23 M(+30.0%) |
| Dec 2020 | $5.56 M(-11.7%) | $5.56 M(-25.7%) |
| Sep 2020 | - | $7.48 M(+46.7%) |
| Jun 2020 | - | $5.10 M(-43.8%) |
| Mar 2020 | - | $9.08 M(+44.2%) |
| Dec 2019 | $6.30 M(+153.0%) | $6.30 M(-16.4%) |
| Sep 2019 | - | $7.53 M(+15.9%) |
| Jun 2019 | - | $6.50 M(+94.7%) |
| Mar 2019 | - | $3.34 M(+34.1%) |
| Dec 2018 | $2.49 M(+53.3%) | $2.49 M(+1.9%) |
| Sep 2018 | - | $2.44 M(-23.3%) |
| Jun 2018 | - | $3.18 M(+96.1%) |
| Dec 2017 | $1.62 M(+181.5%) | $1.62 M |
| Dec 2016 | $577.00 K | - |
FAQ
- What is Sutro Biopharma annual accounts receivable?
- What is the all time high annual accounts receivable for Sutro Biopharma?
- What is Sutro Biopharma annual accounts receivable year-on-year change?
- What is Sutro Biopharma quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Sutro Biopharma?
- What is Sutro Biopharma quarterly accounts receivable year-on-year change?
What is Sutro Biopharma annual accounts receivable?
The current annual accounts receivable of STRO is $36.08 M
What is the all time high annual accounts receivable for Sutro Biopharma?
Sutro Biopharma all-time high annual accounts receivable is $36.08 M
What is Sutro Biopharma annual accounts receivable year-on-year change?
Over the past year, STRO annual accounts receivable has changed by +$28.96 M (+406.57%)
What is Sutro Biopharma quarterly accounts receivable?
The current quarterly accounts receivable of STRO is $6.66 M
What is the all time high quarterly accounts receivable for Sutro Biopharma?
Sutro Biopharma all-time high quarterly accounts receivable is $97.67 M
What is Sutro Biopharma quarterly accounts receivable year-on-year change?
Over the past year, STRO quarterly accounts receivable has changed by -$29.42 M (-81.55%)